Clinical application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography radiomics-based machine learning analyses in the field of oncology

[1]  Zhenxing Jiang,et al.  The predictive value of [18F]FDG PET/CT radiomics combined with clinical features for EGFR mutation status in different clinical staging of lung adenocarcinoma , 2023, EJNMMI Research.

[2]  V. Berti,et al.  Characterization of Mediastinal Bulky Lymphomas with FDG-PET-Based Radiomics and Machine Learning Techniques , 2023, Cancers.

[3]  Kei Yamada,et al.  Four-dimensional quantitative analysis using FDG-PET in clinical oncology , 2023, Japanese Journal of Radiology.

[4]  M. Hatt,et al.  Multicentric development and evaluation of ^18F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer , 2023, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  Y. Hu,et al.  Improving the Classification of PCNSL and Brain Metastases by Developing a Machine Learning Model Based on 18F-FDG PET , 2023, Journal of personalized medicine.

[6]  G. Huang,et al.  Machine Learning Model Based on Optimized Radiomics Feature from 18F-FDG-PET/CT and Clinical Characteristics Predicts Prognosis of Multiple Myeloma: A Preliminary Study , 2023, Journal of clinical medicine.

[7]  Shaoli Song,et al.  Preoperative 18F-FDG PET/CT radiomics analysis for predicting HER2 expression and prognosis in gastric cancer , 2023, Quantitative imaging in medicine and surgery.

[8]  M. Wang,et al.  Developing a primary tumor and lymph node 18F-FDG PET/CT-clinical (TLPC) model to predict lymph node metastasis of resectable T2-4 NSCLC , 2022, Journal of Cancer Research and Clinical Oncology.

[9]  Su Jin Lee,et al.  A Machine Learning Approach Using PET/CT-based Radiomics for Prediction of PD-L1 Expression in Non-small Cell Lung Cancer , 2022, AntiCancer Research.

[10]  Zhaobang Liu,et al.  A multidomain fusion model of radiomics and deep learning to discriminate between PDAC and AIP based on 18F-FDG PET/CT images , 2022, Japanese Journal of Radiology.

[11]  Eiryo Kawakami,et al.  Predicting pathological highly invasive lung cancer from preoperative [18F]FDG PET/CT with multiple machine learning models , 2022, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  Hongzan Sun,et al.  Development of machine learning models integrating PET/CT radiomic and immunohistochemical pathomic features for treatment strategy choice of cervical cancer with negative pelvic lymph node by mediating COX-2 expression , 2022, Frontiers in Physiology.

[13]  Clemens P. Spielvogel,et al.  Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer , 2022, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  J. A. van der Heide,et al.  Machine learning classification of mediastinal lymph node metastasis in NSCLC: a multicentre study in a Western European patient population , 2022, EJNMMI Physics.

[15]  Alejandro F Frangi,et al.  Utility of pre-treatment FDG PET/CT–derived machine learning models for outcome prediction in classical Hodgkin lymphoma , 2022, European Radiology.

[16]  Xuelei Ma,et al.  Computer-aided diagnostic models to classify lymph node metastasis and lymphoma involvement in enlarged cervical lymph nodes using PET/CT. , 2022, Medical physics.

[17]  Clemens P. Spielvogel,et al.  Multi-lesion radiomics of PET/CT for non-invasive survival stratification and histologic tumor risk profiling in patients with lung adenocarcinoma , 2022, European Radiology.

[18]  M. Bertolini,et al.  Novel Harmonization Method for Multi-Centric Radiomic Studies in Non-Small Cell Lung Cancer , 2022, Current oncology.

[19]  T. Yoshiura,et al.  The Usefulness of Machine Learning–Based Evaluation of Clinical and Pretreatment [^18F]-FDG-PET/CT Radiomic Features for Predicting Prognosis in Hypopharyngeal Cancer , 2022, Molecular Imaging and Biology.

[20]  Li Yang,et al.  Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT , 2022, EBioMedicine.

[21]  A. Murali,et al.  Radiomic Analysis of Positron-Emission Tomography and Computed Tomography Images to Differentiate between Multiple Myeloma and Skeletal Metastases , 2022, Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India.

[22]  L. Papp,et al.  Two-Year Event-Free Survival Prediction in DLBCL Patients Based on In Vivo Radiomics and Clinical Parameters , 2022, Frontiers in Oncology.

[23]  J. L. Herraiz,et al.  Analysis of Cross-Combinations of Feature Selection and Machine-Learning Classification Methods Based on [18F]F-FDG PET/CT Radiomic Features for Metabolic Response Prediction of Metastatic Breast Cancer Lesions , 2022, Cancers.

[24]  Semra Özdemir,et al.  Diagnostic Performance of Machine Learning Models Based on 18F-FDG PET/CT Radiomic Features in the Classification of Solitary Pulmonary Nodules , 2022, Molecular imaging and radionuclide therapy.

[25]  Wei Han,et al.  The Machine Learning Model for Distinguishing Pathological Subtypes of Non-Small Cell Lung Cancer , 2022, Frontiers in Oncology.

[26]  Patrick E. Meyer,et al.  Distinction of Lymphoma from Sarcoidosis on 18F-FDG PET/CT: Evaluation of Radiomics-Feature–Guided Machine Learning Versus Human Reader Performance , 2022, The Journal of Nuclear Medicine.

[27]  Haipeng Tong,et al.  A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell Lung Cancer: A Retrospective Multicohort Study , 2022, Frontiers in Immunology.

[28]  E. Klang,et al.  FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study , 2022, European Radiology.

[29]  Alejandro F. Frangi,et al.  Discovery of Pre-Treatment FDG PET/CT-Derived Radiomics-Based Models for Predicting Outcome in Diffuse Large B-Cell Lymphoma , 2022, Cancers.

[30]  T. Yoshiura,et al.  The efficacy of 18F-FDG-PET-based radiomic and deep-learning features using a machine-learning approach to predict the pathological risk subtypes of thymic epithelial tumors. , 2022, The British journal of radiology.

[31]  Zhengyang Zhou,et al.  Radiomics signature from [18F]FDG PET images for prognosis predication of primary gastrointestinal diffuse large B cell lymphoma , 2022, European Radiology.

[32]  Zhengyang Zhou,et al.  Optimal PET-based radiomic signature construction based on the cross-combination method for predicting the survival of patients with diffuse large B-cell lymphoma , 2022, European Journal of Nuclear Medicine and Molecular Imaging.

[33]  Ji-gang Yang,et al.  Prediction for Mitosis-Karyorrhexis Index Status of Pediatric Neuroblastoma via Machine Learning Based 18F-FDG PET/CT Radiomics , 2022, Diagnostics.

[34]  K. Hirata,et al.  Artificial intelligence for nuclear medicine in oncology , 2022, Annals of Nuclear Medicine.

[35]  Shaoli Song,et al.  Classification of solid pulmonary nodules using a machine-learning nomogram based on 18F-FDG PET/CT radiomics integrated clinicobiological features , 2022, Annals of translational medicine.

[36]  Shaoli Song,et al.  18F-FDG PET/CT radiomic analysis for classifying and predicting microvascular invasion in hepatocellular carcinoma and intrahepatic cholangiocarcinoma , 2022, Quantitative imaging in medicine and surgery.

[37]  T. Kwee,et al.  Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic [18F]FDG PET/CT features , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[38]  T. Yoshiura,et al.  Machine learning based evaluation of clinical and pretreatment 18F-FDG-PET/CT radiomic features to predict prognosis of cervical cancer patients , 2021, Abdominal Radiology.

[39]  M. Akyol,et al.  IMPORTANCE of PRETREATMENT 18F-FDG PET/CT TEXTURE ANALYSIS in PREDICTING EGFR and ALK MUTATION in PATIENTS with NON-SMALL CELL LUNG CANCER , 2021, Nuklearmedizin - NuclearMedicine.

[40]  Xiuying Wang,et al.  Radiomic analysis for predicting prognosis of colorectal cancer from preoperative 18F-FDG PET/CT , 2021, Journal of translational medicine.

[41]  Wei Chen,et al.  Prediction of HER2 expression in breast cancer by combining PET/CT radiomic analysis and machine learning , 2021, Annals of Nuclear Medicine.

[42]  E. Neri,et al.  Human, All Too Human? An All-Around Appraisal of the “Artificial Intelligence Revolution” in Medical Imaging , 2021, Frontiers in Psychology.

[43]  Xiuying Wang,et al.  18F-FDG PET/CT Radiomics for Preoperative Prediction of Lymph Node Metastases and Nodal Staging in Gastric Cancer , 2021, Frontiers in Oncology.

[44]  S. Jeong,et al.  Prediction Model for Tumor Budding Status Using the Radiomic Features of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Cervical Cancer , 2021, Diagnostics.

[45]  Xiuying Wang,et al.  Quantitative Prediction of Microsatellite Instability in Colorectal Cancer With Preoperative PET/CT-Based Radiomics , 2021, Frontiers in Oncology.

[46]  R. Gillies,et al.  Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images , 2021, Journal for ImmunoTherapy of Cancer.

[47]  Y. Tsushima,et al.  Texture analysis of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography for predicting the treatment response of postoperative recurrent or metastatic oral squamous cell carcinoma treated with cetuximab , 2021, Annals of Nuclear Medicine.

[48]  Kyle J. Lafata,et al.  Intrinsic radiomic expression patterns after 20 Gy demonstrate early metabolic response of oropharyngeal cancers. , 2021, Medical physics.

[49]  M. Hatt,et al.  Comparison and Fusion of Machine Learning Algorithms for Prospective Validation of PET/CT Radiomic Features Prognostic Value in Stage II-III Non-Small Cell Lung Cancer , 2021, Diagnostics.

[50]  Patrick E. Meyer,et al.  [18F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[51]  T. Yoshiura,et al.  Application of a Machine Learning Approach for the Analysis of Clinical and Radiomic Features of Pretreatment [18F]-FDG PET/CT to Predict Prognosis of Patients with Endometrial Cancer , 2021, Molecular Imaging and Biology.

[52]  Quanshi Wang,et al.  Preoperative prediction of regional lymph node metastasis of colorectal cancer based on 18F-FDG PET/CT and machine learning , 2021, Annals of Nuclear Medicine.

[53]  Gang Wang,et al.  A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts ALK Rearrangement Status in Lung Adenocarcinoma , 2021, Frontiers in Oncology.

[54]  Clemens P. Spielvogel,et al.  Breast Tumor Characterization Using [18F]FDG-PET/CT Imaging Combined with Data Preprocessing and Radiomics , 2021, Cancers.

[55]  L. Huo,et al.  Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on 18F-FDG PET/CT radiomics , 2021, EJNMMI Research.

[56]  I. Castiglioni,et al.  Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[57]  Xuelei Ma,et al.  Use of radiomics based on 18F-FDG PET/CT and machine learning methods to aid clinical decision-making in the classification of solitary pulmonary lesions: an innovative approach , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[58]  B. Song.  A machine learning-based radiomics model for the prediction of axillary lymph-node metastasis in breast cancer , 2021, Breast Cancer.

[59]  R. Gillies,et al.  Non-invasive decision support for NSCLC treatment using PET/CT radiomics , 2020, Nature Communications.

[60]  Chi Liu,et al.  Prediction of post-radiotherapy locoregional progression in HPV-associated oropharyngeal squamous cell carcinoma using machine-learning analysis of baseline PET/CT radiomics , 2020, Translational oncology.

[61]  Shaoli Song,et al.  Machine learning based on clinico-biological features integrated 18F-FDG PET/CT radiomics for distinguishing squamous cell carcinoma from adenocarcinoma of lung , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[62]  F. Motoi,et al.  Prognostic value of FDG-PET radiomics with machine learning in pancreatic cancer , 2020, Scientific Reports.

[63]  Hongzan Sun,et al.  Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma , 2020, BMC Cancer.

[64]  A. Scarsbrook,et al.  Machine learning-based FDG PET-CT radiomics for outcome prediction in larynx and hypopharynx squamous cell carcinoma. , 2020, Clinical radiology.

[65]  Tao Yu,et al.  Prognostic value of the baseline 18F-FDG PET/CT metabolic tumour volume (MTV) and further stratification in low-intermediate (L-I) and high-intermediate (H-I) risk NCCNIPI subgroup by MTV in DLBCL MTV predict prognosis in DLBCL , 2020, Annals of Nuclear Medicine.

[66]  Weidong Wang,et al.  Development of a Radiomics Prediction Model for Histological Type Diagnosis in Solitary Pulmonary Nodules: The Combination of CT and FDG PET , 2020, Frontiers in Oncology.

[67]  F. Zhang,et al.  Histologic subtype classification of non-small cell lung cancer using PET/CT images , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[68]  A. Aksu,et al.  Evaluating Focal 18F-FDG Uptake in Thyroid Gland with Radiomics , 2020, Nuclear Medicine and Molecular Imaging.

[69]  Zheran Liu,et al.  Radiomics-based prediction of survival in patients with head and neck squamous cell carcinoma based on pre- and post-treatment 18F-PET/CT , 2020, Aging.

[70]  T. Frauenfelder,et al.  FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients , 2020, EJNMMI Research.

[71]  M. Prasad,et al.  Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma , 2020, Cancers.

[72]  D. Feng,et al.  Predicting EGFR mutation subtypes in lung adenocarcinoma using 18F-FDG PET/CT radiomic features , 2020, Translational lung cancer research.

[73]  M. Prasad,et al.  PET/CT radiomics signature of human papilloma virus association in oropharyngeal squamous cell carcinoma , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[74]  Wei-Chih Shen,et al.  Predicting pathological complete response in rectal cancer after chemoradiotherapy with a random forest using 18F-fluorodeoxyglucose positron emission tomography and computed tomography radiomics , 2020, Annals of translational medicine.

[75]  A. Sabri,et al.  Radiogenomic Models Using Machine Learning Techniques to Predict EGFR Mutations in Non-Small Cell Lung Cancer , 2020, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[76]  Xiuying Wang,et al.  18F-FDG PET/CT radiomic predictors of pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer patients , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[77]  R. Gillies,et al.  Radiomics of 18F-FDG PET/CT images predicts clinical benefit of advanced NSCLC patients to checkpoint blockade immunotherapy , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[78]  Xuelei Ma,et al.  Radiomics based on 18F‐FDG PET/CT could differentiate breast carcinoma from breast lymphoma using machine‐learning approach: A preliminary study , 2019, Cancer medicine.

[79]  Wengui Xu,et al.  Potential feature exploration and model development based on 18F-FDG PET/CT images for differentiating benign and malignant lung lesions. , 2019, European journal of radiology.

[80]  Wenjuan Ma,et al.  Predictive Power of a Radiomic Signature Based on 18F-FDG PET/CT Images for EGFR Mutational Status in NSCLC , 2019, Front. Oncol..

[81]  Xiaodong Yang,et al.  Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in 18 F-FDG PET/CT. , 2019, Medical physics.

[82]  M. Gnant,et al.  Breast cancer , 2019, Nature Reviews Disease Primers.

[83]  A. Rahmim,et al.  Machine Learning Methods for Optimal Radiomics-Based Differentiation Between Recurrence and Inflammation: Application to Nasopharyngeal Carcinoma Post-therapy PET/CT Images , 2019, Molecular Imaging and Biology.

[84]  R. Wahl,et al.  18F-FDG PET/CT Radiomic Analysis with Machine Learning for Identifying Bone Marrow Involvement in the Patients with Suspected Relapsed Acute Leukemia , 2019, Theranostics.

[85]  Hassan Maleki,et al.  Next Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Approaches , 2019, ArXiv.

[86]  S. Hyun,et al.  Pre-treatment 18F-FDG PET-based radiomics predict survival in resected non-small cell lung cancer. , 2019, Clinical radiology.

[87]  M. Astaraki,et al.  Early survival prediction in non-small cell lung cancer from PET/CT images using an intra-tumor partitioning method. , 2019, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[88]  C. Fuller,et al.  A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma , 2019, Scientific Reports.

[89]  G. Chong,et al.  Tumor Budding is a Valuable Diagnostic Parameter in Prediction of Disease Progression of Endometrial Endometrioid Carcinoma , 2019, Pathology & Oncology Research.

[90]  Peter Szolovits,et al.  Artificial intelligence, machine learning and health systems , 2018, Journal of global health.

[91]  Xiuhua Guo,et al.  Intra-tumoural heterogeneity characterization through texture and colour analysis for differentiation of non-small cell lung carcinoma subtypes , 2018, Physics in medicine and biology.

[92]  A. Rahmim,et al.  Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal 18F-FDG PET/CT images , 2018 .

[93]  S. Hohaus,et al.  FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET) , 2018, Annals of Nuclear Medicine.

[94]  A. Shaw,et al.  Tumour heterogeneity and resistance to cancer therapies , 2018, Nature Reviews Clinical Oncology.

[95]  Roy S. Herbst,et al.  The biology and management of non-small cell lung cancer , 2018, Nature.

[96]  P. Lambin,et al.  Radiomics: the bridge between medical imaging and personalized medicine , 2017, Nature Reviews Clinical Oncology.

[97]  H. Okazawa,et al.  18F-FDG PET radiomics approaches: comparing and clustering features in cervical cancer , 2017, Annals of Nuclear Medicine.

[98]  Phil Quirke,et al.  Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016 , 2017, Modern Pathology.

[99]  B. Erickson,et al.  Machine Learning for Medical Imaging. , 2017, Radiographics : a review publication of the Radiological Society of North America, Inc.

[100]  C. Thorns,et al.  Expression of cyclooxygenase-2 in cervical cancer is associated with lymphovascular invasion , 2016, Oncology letters.

[101]  S. Hohaus,et al.  Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET) , 2016, Annals of Nuclear Medicine.

[102]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[103]  Paul Kinahan,et al.  Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.

[104]  K. Kawaguchi,et al.  Comparisons of the clinicopathological features and survival outcomes between lung cancer patients with adenocarcinoma and squamous cell carcinoma , 2015, General Thoracic and Cardiovascular Surgery.

[105]  Martin L. Miller,et al.  Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer , 2015, Science.

[106]  D. Eisele,et al.  The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. , 2014, Oral oncology.

[107]  S. Palaniswamy,et al.  Diagnostic utility of PETCT in thyroid malignancies: an update , 2013, Annals of Nuclear Medicine.

[108]  Hiroshi Honda,et al.  Impact of FDG-PET/CT in the management of lymphoma , 2011, Annals of nuclear medicine.

[109]  Yan-mei Yang,et al.  COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer. , 2011, Microvascular research.

[110]  Akbar K Waljee,et al.  Machine Learning in Medicine: A Primer for Physicians , 2010, The American Journal of Gastroenterology.

[111]  Thomas F Hany,et al.  Integrated PET/CT: current applications and future directions. , 2006, Radiology.

[112]  K. Togashi,et al.  Usefulness of gradient tree boosting for predicting histological subtype and EGFR mutation status of non-small cell lung cancer on 18F FDG-PET/CT , 2019, Annals of Nuclear Medicine.

[113]  M. Pfreundschuh,et al.  Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.